Please be advised: MSK has not registered to be a designated vaccine site for the general public at this time. Two MSK locations were incorrectly listed and we have contacted the New York State Department of Health to update their website.
The focus of our research is to understand the global genetic determinants of cancer development and therapeutic response. We primarily utilize data generated by next-generation sequencing technologies to study genomic mutations, copy number alterations, structural variations, and transcriptome changes, which together provide a molecular profile of individual tumors.
We collaborate closely with clinical investigators and researchers to integrate molecular and clinical information so as to identify molecular determinants of clinical phenotypes, thereby allowing more precise stratification of patient populations and targeting of cancer therapeutics.